BiotechTube
Home/Lexicon Pharmaceuticals/Alan J. Main, Ph.D.
AJ

Alan J. Main, Ph.D.

Executive Vice President, Research & Development and Chief Scientific Officer

Lexicon Pharmaceuticals

Therapeutic Areas

CardiovascularMetabolicNeuropathic PainNeurology

Lexicon Pharmaceuticals Pipeline

DrugIndicationPhase
INPEFA (sotagliflozin)Heart FailureApproved
LX9211Diabetic Peripheral Neuropathic Pain (DPNP)Phase 2

Leadership Team at Lexicon Pharmaceuticals

LC
Lonnel Coats
Chief Executive Officer
JL
Jeffrey L. Wade
President, Chief Financial Officer & Corporate Secretary
CA
Craig A. Granowitz, M.D., Ph.D.
Senior Vice President & Chief Medical Officer
BT
Brian T. Crum
Senior Vice President, Corporate Affairs & Investor Relations
AM
Arthur M. Pappas
Chairman of the Board of Directors
DL
David L. Southwell
Director
JF
John F. Kouten
Director
KA
Keith A. Sutton
Director
HP
H. Paul Dorman
Director
WJ
W. James O'Shea
Director
View full Lexicon Pharmaceuticals profile